Clinical- and Genomic-Based Decision-Support System to Define the Optimal Timing of Allogeneic HSCT in Patients With Myelodysplastic Syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
J. Clin. Oncol 2024 May 09;[EPub Ahead of Print], CA Tentori, C Gregorio, M Robin, N Gagelmann, C Gurnari, S Ball, JC Caballero Berrocal, L Lanino, S D'Amico, M Spreafico, G Maggioni, E Travaglino, E Sauta, M Meggendorfer, LP Zhao, A Campagna, , V Savevski, A Santoro, N Al Ali, D Sallman, F Sole, G Garcia-Manero, U Germing, N Kroger, S Kordasti, V Santini, G Sanz, W Kern, U Platzbecker, M Diez-Campelo, JP Maciejewski, L Ades, P Fenaux, T Haferlach, AM Zeidan, G Castellani, R Komrokji, F Ieva, MG Della PortaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.